Introduction

Hemoglobin A1c (HbA1c) is a vital biomarker used to monitor long-term glucose control in individuals with diabetes mellitus. It reflects the average blood glucose levels over the previous 2 to 3 months by measuring the glycation of hemoglobin molecules in red blood cells. This article explains the biochemical basis of HbA1c formation, focusing on the specific amino acid residue on the globin chain where glucose attaches.

What Is HbA1c?

• HbA1c is a form of glycated hemoglobin formed when glucose molecules bind non-enzymatically to hemoglobin.

• The extent of glycation correlates directly with blood glucose levels, making HbA1c a reliable indicator of chronic glycemia.

• The average lifespan of red blood cells (~120 days) allows HbA1c to reflect glucose exposure during this period.

Site of Glucose Attachment on Hemoglobin

• Hemoglobin is a tetramer made of two alpha (α) and two beta (β) chains.

• The glucose molecule attaches predominantly to the N-terminal valine residue of each β-globin chain.

• This glycation is a non-enzymatic process that forms a reversible Schiff base initially, later undergoing an Amadori rearrangement to form a stable ketoamine linkage.

• The N-terminal valine residue provides a primary amino group suitable for this reaction.

Why Not Other Residues?

• Lysine residues are also present but contribute minimally to HbA1c formation.

• The specific reaction site on the β chain’s N-terminal valine is more accessible and reactive to glucose during the normal circulation time of red blood cells.

Clinical Relevance

• HbA1c level monitoring is essential for diagnosing diabetes and guiding therapy adjustments.

• Higher HbA1c values indicate poorer glycemic control and correlate with increased risk of diabetic complications such as retinopathy, nephropathy, and cardiovascular disease.

Summary Table

Conclusion

The glucose molecule in HbA1c primarily attaches to the N-terminal valine residue of each β-globin chain of hemoglobin, making option:

(4) Valine of each β chain